A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma

Westphal, Manfred; Heese, Oliver; Steinbach, Joachim P.; Schnell, Oliver; Schackert, Gabriele; Mehdorn, Maximilian; Schulz, Dirk; Simon, Matthias; Schlegel, Uwe; Senft, Christian; Geletneky, Karsten; Braun, Christian; Hartung, Joachim G.; Reuter, Dirk; Metz, Monika Warmuth; Bach, Ferdinand; Pietsch, Torsten

dc.contributor.author	Braun, Christian
dc.date.accessioned	2015-11-16T12:36:47Z
dc.date.available	2015-11-16T12:36:47Z
dc.date.issued	2015
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/10900/66439
dc.language.iso	en	en
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.ejca.2014.12.019
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_01502
utue.publikation.seiten	522-532	de_DE
utue.personen.roh	Westphal, Manfred
utue.personen.roh	Heese, Oliver
utue.personen.roh	Steinbach, Joachim P.
utue.personen.roh	Schnell, Oliver
utue.personen.roh	Schackert, Gabriele
utue.personen.roh	Mehdorn, Maximilian
utue.personen.roh	Schulz, Dirk
utue.personen.roh	Simon, Matthias
utue.personen.roh	Schlegel, Uwe
utue.personen.roh	Senft, Christian
utue.personen.roh	Geletneky, Karsten
utue.personen.roh	Braun, Christian
utue.personen.roh	Hartung, Joachim G.
utue.personen.roh	Reuter, Dirk
utue.personen.roh	Metz, Monika Warmuth
utue.personen.roh	Bach, Ferdinand
utue.personen.roh	Pietsch, Torsten
dcterms.isPartOf.ZSTitelID	European Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	51	de_DE
utue.fakultaet	04 Medizinische Fakultät